1-8 of 8
Eric Vivier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6582: Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors

Romain Remark, Cécile Bonnafous, Laura Chiossone, Caroline Soulas, Cyril Perrier, Guillaume Habif, Sivan Bokobza, Aurélie Maguer, Rachel Courtois, Julie Lopez, Grégory Fenaux, Olivier Benac, Barbara Carrette, Robin Letay-Drouet, Raja Bonifay, Séverine Augier, Léa Simon, Benjamin Rossi, Ariane Morel, Agnès Represa, Nicola Beltraminelli, Yannis Morel, Carine Paturel, Eric Vivier
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6582.
https://doi.org/10.1158/1538-7445.AM2024-6582
Published: 22 March 2024
View article titled, Abstract 6582: Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors
Journal Articles

Abstract 2960: The novel trifunctional anti-BCMA NK cell engager SAR’514 has potent in-vitro, in-vivo and ex-vivo anti-myeloma effect through dual NK cell engagement

Alexandre Tang, Laurent Gauthier, Jochen Beninga, Benjamin Rossi, Nicolas Gourdin, Audrey Blanchard-Alvarez, Céline Amara, Jacqueline Courta, Alexandra Basset, Dorothée Bourges, Alexandre Desjonqueres, Emmanuelle Menoret, Catherine Pellat-Deceunynck, Philippe Moreau, Yannis Morel, Marielle Chiron, Eric Vivier, Angela Virone-Oddos
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2960.
https://doi.org/10.1158/1538-7445.AM2023-2960
Published: 04 April 2023
View article titled, Abstract 2960: The novel trifunctional anti-BCMA NK cell engager SAR’514 has potent <em>in-vitro</em>, <em>in-vivo</em> and <em>ex-vivo</em> anti-myeloma effect through dual NK cell engagement
Journal Articles

Abstract LB120: Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial

Laurent Greillier, Florence Monville, Vanina Leca, Frédéric Vely, Stephane Garcia, Joseph Ciccolini, Florence Sabatier, Gilbert Ferrani, Nawel Boudai, Lamia Ghezali, Marcellin Landri, Clémence Marin, Mourad Hamimed, Laurent Arnaud, Melanie Karlsen, Kevin Atsou, Sivan Bokobza, Pauline Fleury, Arnaud Boyer, Clarisse Audigier-Valette, Stéphanie Martinez, Hervé Pegliasco, Patrice Ray, Lionel Falchero, Antoine Serre, Nicolas Cloarec, Louisiane Lebas, Stephane Hominal, Patricia Barre, Sarah Zahi, Ahmed Frikha, Pierre Bory, Maryannick Le Ray, Lilian Laborde, Virginie Martin, Richard Malkoun, Marie Roumieux, Julien Mazieres, Maurice Perol, Eric Vivier, Sebastien Benzekry, Jacques Fieschi, Fabrice Barlesi
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB120.
https://doi.org/10.1158/1538-7445.AM2022-LB120
Published: 15 June 2022
View article titled, Abstract LB120: Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial
Journal Articles

Abstract 1690: NKG2A immune checkpoint blockade potentiates cetuximab induced ADCC in head and neck cancer preclinical model

Caroline Soulas, Ana Lalanne, Cécile Bonnafous, Caroline Hoffman, Elodie Bonnet, Arnaud Dujardin, Violette Breso, Mathieu Bléry, Olivier Lantz, Romain Remark, Eric Vivier, Pascale Andre
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 1690.
https://doi.org/10.1158/1538-7445.AM2018-1690
Published: 01 July 2018
View article titled, Abstract 1690: NKG2A immune checkpoint blockade potentiates cetuximab induced ADCC in head and neck cancer preclinical model
Journal Articles

Abstract 2714: Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers

Caroline Soulas, Romain Remark, Vedran Brezar, Julie Lopez, Elodie Bonnet, Flavien Caraguel, Ana Lalanne, Caroline Hoffmann, Caroline Denis, Thomas Arnoux, Clarisse Caillet, Arnaud Dujardin, Guillaume Habif, Olivier Lantz, Cécile Bonnafous, Eric Vivier, Pascale Andre
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2714.
https://doi.org/10.1158/1538-7445.AM2018-2714
Published: 01 July 2018
View article titled, Abstract 2714: Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers
Journal Articles

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment

Arabella Young, Shin Foong Ngiow, Yulong Gao, Ann-Marie Patch, Deborah S. Barkauskas, Meriem Messaoudene, Gene Lin, Jerome D. Coudert, Kimberley A. Stannard, Laurence Zitvogel, Mariapia A. Degli-Esposti, Eric Vivier, Nicola Waddell, Joel Linden, Nicholas D. Huntington, Fernando Souza-Fonseca-Guimaraes, Mark J. Smyth
Journal: Cancer Research
Cancer Res (2018) 78 (4): 1003–1016.
https://doi.org/10.1158/0008-5472.CAN-17-2826
Published: 14 February 2018
View article titled, A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Open the PDF for A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Abstract 493: Antitumoral efficacy of therapeutic human anti-KIR antibody (BMS-986015/IPH2102) in a preclinical xenograft tumor model.

Caroline Sola, Fabien Chanuc, Ariane Thielens, Nicolas Fuseri, Isabelle Palacios, Mathieu Blery, Pascale André, Eric Vivier, Sophie Ugolini, Robert Graziano, François Romagne, Cécile Bonnafous
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 493.
https://doi.org/10.1158/1538-7445.AM2013-493
Published: 15 April 2013
View article titled, Abstract 493: Antitumoral efficacy of therapeutic human anti-KIR antibody (BMS-986015/IPH2102) in a preclinical xenograft tumor model.
Journal Articles

Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma

Hiroshi Nakagomi, Max Petersson, Inger Magnusson, Claes Juhlin, Masanori Matsuda, Håkan Mellstedt, Jean-Luc Taupin, Eric Vivier, Paul Anderson, Rolf Kiessling
Journal: Cancer Research
Cancer Res (1993) 53 (23): 5610–5612.
Published: 01 December 1993
View article titled, Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma
Open the PDF for Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma in another window